宝莱特：2025年前三季度净利润约-834万元

Group 1 - Company Baolait reported a revenue of approximately 793 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 1.77% [1] - The net profit attributable to shareholders of the listed company was a loss of approximately 8.34 million yuan, with a basic earnings per share loss of 0.0315 yuan [1] - As of the report date, Baolait's market capitalization stood at 2.3 billion yuan [2] Group 2 - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion US dollars this year [2] - The secondary market for biomedicine is experiencing a surge, while the primary market is facing challenges in fundraising [2]